Skip to main content

Quince Therapeutics, Inc.

QNCX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001662774

No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Quince Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
45
−3 vs. Q4 2022
Shares held
7.68M
+2.29M (+42.4%) vs. Q4 2022
Total value
$12.0M
+$8.54M (+248.9%) vs. Q4 2022
New holders
5
6 more added
Sold out
8
14 more reduced

2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 45 institutions
Q1 2021: 91 institutionsQ2 2021: 105 institutionsQ3 2021: 131 institutionsQ4 2021: 102 institutionsQ1 2022: 88 institutionsQ2 2022: 70 institutionsQ3 2022: 61 institutionsQ4 2022: 50 institutionsQ1 2023: 45 institutionsQ2 2023: 40 institutionsQ3 2023: 42 institutionsQ4 2023: 44 institutionsQ1 2024: 46 institutionsQ2 2024: 43 institutionsQ3 2024: 33 institutionsQ4 2024: 35 institutionsQ1 2025: 36 institutionsQ2 2025: 41 institutionsQ3 2025: 45 institutionsQ4 2025: 67 institutionsQ1 2026: 46 institutionsQ2 2026: 26 institutions
Value heldQ1 2023: $12.0M
Q1 2021: $673.5MQ2 2021: $982.9MQ3 2021: $1.76BQ4 2021: $242.8MQ1 2022: $99.5MQ2 2022: $26.0MQ3 2022: $12.4MQ4 2022: $3.44MQ1 2023: $12.0MQ2 2023: $13.5MQ3 2023: $8.40MQ4 2023: $7.83MQ1 2024: $7.71MQ2 2024: $4.68MQ3 2024: $4.04MQ4 2024: $9.55MQ1 2025: $6.96MQ2 2025: $12.5MQ3 2025: $19.2MQ4 2025: $67.5MQ1 2026: $1.44MQ2 2026: $4.74M
Institutions holding QNCX and their total value by quarter
QuarterHoldersValue
Q2 202626$4.74M
Q1 202646$1.44M
Q4 202567$67.5M
Q3 202545$19.2M
Q2 202541$12.5M
Q1 202536$6.96M
Q4 202435$9.55M
Q3 202433$4.04M
Q2 202443$4.68M
Q1 202446$7.71M
Q4 202344$7.83M
Q3 202342$8.40M
Q2 202340$13.5M
Q1 202345$12.0M
Q4 202250$3.44M
Q3 202261$12.4M
Q2 202270$26.0M
Q1 202288$99.5M
Q4 2021102$242.8M
Q3 2021131$1.76B
Q2 2021105$982.9M
Q1 202191$673.5M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q4 2022.

Institutions holding QNCX in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Tang Capital Management LLC3,620,000$5.65M0.84%+3,620,000New
EPIQ Capital Group, LLC958,469$1.50M0.78%−97,722−9.3%Reduced
Vanguard Group Inc893,291$1.39M0.00%+39,900+4.7%Added
Two Sigma Advisers, LP405,000$631.8K0.00%−23,800−5.6%Reduced
BlackRock Inc.323,906$505.3K0.00%−26,248−7.5%Reduced
Millennium Management LLC248,013$387.0K0.00%−347,788−58.4%Reduced
Renaissance Technologies LLC229,800$358.0K0.00%+75,700+49.1%Added
Alphabet Inc.189,122$295.0K0.02%00.0%Unchanged
Geode Capital Management, LLC137,086$213.9K0.00%00.0%Unchanged
Two Sigma Investments, LP127,086$198.3K0.00%−340,198−72.8%Reduced
Susquehanna International Group, LLP125,526$195.8K0.00%+21,436+20.6%Added
Bridgeway Capital Management, LLC110,000$171.6K0.00%00.0%Unchanged
State Street Corp57,411$89.6K0.00%00.0%Unchanged
Acadian Asset Management LLC46,840$73.0K0.00%−106,948−69.5%Reduced
Northern Trust Corp40,422$63.1K0.00%+6,683+19.8%Added
Hennion & Walsh Asset Management, Inc.31,061$48.0K0.00%−1,063−3.3%Reduced
Susquehanna Fundamental Investments, LLC22,321$34.8K0.00%00.0%Unchanged
Bank of America Corp15,248$23.8K0.00%+12,138+390.3%Added
Strategic Blueprint, LLC12,200$19.0K0.00%00.0%Unchanged
Cohen Lawrence B11,126$17.4K0.01%00.0%Unchanged
Charles Schwab Investment Management Inc11,013$17.2K0.00%00.0%Unchanged
Quantamental Technologies LLC10,867$17.0K0.01%−900−7.6%Reduced
Westmount Partners, LLC10,148$15.8K0.01%00.0%Unchanged
Brinker Capital Investments, LLC10,136$15.8K0.00%−590−5.5%Reduced
Orion Portfolio Solutions, LLC10,136$15.8K0.00%+10,136New
Morgan Stanley9,694$15.1K0.00%−2,065−17.6%Reduced
Citigroup Inc5,165$8.06K0.00%00.0%Unchanged
Parallel Advisors, LLC2,376$3.71K0.00%−65−2.7%Reduced
Advisory Services Network, LLC1,050$1.64K0.00%00.0%Unchanged
Federated Hermes, Inc.801$1.25K0.00%−249,657−99.7%Reduced
BNP Paribas Arbitrage, SA647$1.01K0.00%−562−46.5%Reduced
JPMorgan Chase & Co469$1.00K0.00%00.0%Unchanged
JDM Financial Group LLC340$5300.00%00.0%Unchanged
UBS Group AG325$5070.00%−45,544−99.3%Reduced
Financial Perspectives, Inc310$4840.00%00.0%Unchanged
Advisor Group Holdings, Inc.277$4320.00%00.0%Unchanged
Allworth Financial LP267$4170.00%+267New
Ten Capital Wealth Advisors, LLC163$2540.00%00.0%Unchanged
Wells Fargo & Company147$2290.00%+2+1.4%Added
Financial Avengers, Inc.100$1560.00%00.0%Unchanged
Barclays PLC100$1560.00%+100New
Westside Investment Management, Inc.75$1170.00%00.0%Unchanged
The PNC Financial Services Group, Inc.32$500.00%00.0%Unchanged
Householder Group Estate & Retirement Specialist, LLC100$00.00%00.0%Unchanged
Tower Research Capital LLC (TRC)98$00.00%+98New
State of Wisconsin Investment Board0$00.00%−74,800−100.0%Sold out
Simplex Trading, LLC0$00.00%−66,415−100.0%Sold out
Group One Trading, L.P.0$00.00%−40,745−100.0%Sold out
Ergoteles LLC0$00.00%−39,244−100.0%Sold out
Tri Locum Partners LP0$00.00%−22,269−100.0%Sold out
Citadel Advisors LLC0$00.00%−5,288−100.0%Sold out
Cutler Group LP0$00.00%−5,205−100.0%Sold out
Quantbot Technologies LP0$00.00%−2,800−100.0%Sold out
Burleson & Company, LLC––––Not filed
CoreCap Advisors, LLC––––Not filed